RAGE Inhibitor TTP488 (Azeliragon) Suppresses Metastasis in Triple-Negative Breast Cancer

Transcriptomic analysis of primary xenograft tumor and metastatic tissue revealed high concordance in gene and protein changes with both drugs, with TTP488 showing greater potency against metastatic driver pathways.